Manuel Francisco Ugarte-Gil
Manuel Francisco Ugarte-Gil publishes mostly in Rheumatology, Infectious Diseases and Pathology and Forensic Medicine, on topics such as Systemic Lupus Erythematosus Research, Rheumatoid Arthritis Research and Therapies and Systemic Sclerosis and Related Diseases.
- World rank
- #771,908 of 7,710,434 ranked researchers
- Rank in Peru
- #187 of 7,808
- Works
- 323
- Citations
- 5.3k
- Citations per work
- 16.5
What does Manuel Francisco Ugarte-Gil research?
Manuel Francisco Ugarte-Gil's work is mostly in Medicine (62%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences20162.2%
- Medicine20162.2%
- Everything else10432.2%
- Life Sciences185.6%
- 1Rheumatology40% of their works
- 2Infectious Diseases8% of their works
- 3Pathology and Forensic Medicine7% of their works
- 4Immunology6% of their works
- 5Epidemiology4% of their works
- 6Hematology4% of their works
Research topics
- Systemic Lupus Erythematosus Research
- Rheumatoid Arthritis Research and Therapies
- Systemic Sclerosis and Related Diseases
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Atherosclerosis and Cardiovascular Diseases
- Autoimmune and Inflammatory Disorders Research
- Vasculitis and related conditions
Which keywords describe Manuel Francisco Ugarte-Gil's research?
The keywords of their largest research topics: Autoantibodies, Antiphospholipid Syndrome, Systemic Lupus Erythematosus, Cytokines, Inflammation, Biological Therapy, Rheumatoid Arthritis and ACE2 Receptor.
- Vasculitides
- Hemophagocytic Lymphohistiocytosis
- Oxidized LDL
- Epidemiology
- Vaccine
- Systemic Sclerosis
- Immune Response
- ACE2 Receptor
- Biological Therapy
- Cytokines
- Antiphospholipid Syndrome
- Autoantibodies
- Systemic Lupus Erythematosus
- Inflammation
- Rheumatoid Arthritis
- SARS-CoV-2
- Fibrosis
- Coronavirus
- Clinical Characteristics
- Atherosclerosis
- ANCA-associated
- Juvenile Idiopathic Arthritis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Autoantibodies3293 topics
- Antiphospholipid Syndrome1891 topic
- Systemic Lupus Erythematosus1891 topic
- Cytokines1322 topics
- Inflammation1322 topics
- Biological Therapy1061 topic
- Rheumatoid Arthritis1061 topic
- ACE2 Receptor562 topics
- SARS-CoV-2562 topics
- Immune Response532 topics
- Fibrosis341 topic
- Systemic Sclerosis341 topic
- Coronavirus291 topic
- Vaccine291 topic
- Clinical Characteristics271 topic
- Epidemiology271 topic
- Atherosclerosis261 topic
- Oxidized LDL261 topic
- ANCA-associated201 topic
- Hemophagocytic Lymphohistiocytosis201 topic
- Juvenile Idiopathic Arthritis201 topic
- Vasculitides201 topic
Where does Manuel Francisco Ugarte-Gil work?
Manuel Francisco Ugarte-Gil's main affiliation in the publication record is Hospital Base Guillermo Almenara Irigoyen, Peru.
How many publications and citations does Manuel Francisco Ugarte-Gil have?
OpenAlex counts 323 works and 5,328 citations for Manuel Francisco Ugarte-Gil, an h-index of 35, ranking #771,908 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Manuel Francisco Ugarte-Gil. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.